Cargando…

Hirudin promotes proliferation and osteogenic differentiation of HBMSCs via activation of cyclic guanosine monophosphate (cGMP)/protein kinase-G (PKG) signaling pathway

Osteoporosis is a public health problem resulting in higher susceptibility to bone fracture. Hirudin is known as a direct thrombin inhibitor, which is isolated from the salivary gland of the medicinal leech. The present study aimed to evaluate the effect of Hirudin on the proliferation and osteogeni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Shun, Li, Xianghui, Feng, Ting, Li, Yaqing, Ding, Hongwei, Xie, Lin, Yang, Quanhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973852/ https://www.ncbi.nlm.nih.gov/pubmed/34898364 http://dx.doi.org/10.1080/21655979.2021.2008697

Ejemplares similares

Inhibition of PDE5A1 guanosine cyclic monophosphate (cGMP) hydrolysing activity by sildenafil analogues that inhibit cellular cGMP efflux
por: Subbotina, Anna, et al.
Publicado: (2017)

The role of cGMP and PKG in cardioprotection
por: Downey, James M, et al.
Publicado: (2009)

Role of cGMP/PKG in fat tissue
por: Pfeifer, Alexander
Publicado: (2011)

Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic‐Banded Mini‐Swine
por: Hiemstra, Jessica A., et al.
Publicado: (2016)

Cyclic GMP and PKG Signaling in Heart Failure
por: Numata, Genri, et al.
Publicado: (2022)

Structures of human PKG reveal cGMP-selectived activation mechanisms
por: Huang, Gilbert Y, et al.
Publicado: (2013)

Cyclic Guanosine Monophosphate (cGMP)-Dependent Protein Kinase II Blocks Epidermal Growth Factor (EGF)/Epidermal Growth Factor Receptor (EGFR)-Induced Biological Effects on Osteosarcoma Cells
por: Li, Dapeng, et al.
Publicado: (2018)

The cyclic guanosine monophosphate synthase-stimulator of interferon genes pathway as a potential target for tumor immunotherapy
por: Chen, Rui, et al.
Publicado: (2023)

cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway
por: Park, Min, et al.
Publicado: (2018)

Monovalent selectivity of the cyclic guanosine monophosphate-activated ion channel
Publicado: (1990)

Regulation of Biofilm Exopolysaccharide Production by Cyclic Di-Guanosine Monophosphate
por: Poulin, Myles B., et al.
Publicado: (2021)

Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF Trial
por: Butt, Jawad H., et al.
Publicado: (2023)

Construction of novel cGMP FRET-sensors based on PKG from Plasmodium falciparum
por: Calamera, Gaia, et al.
Publicado: (2015)

The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies
por: Cai, Zhulan, et al.
Publicado: (2023)

The Role of NO/sGC/cGMP/PKG Signaling Pathway in Regulation of Platelet Function
por: Gambaryan, Stepan
Publicado: (2022)

The crystal structures of PKG Iβ (92-227) with cGMP and cAMP reveal the molecular details of cyclic-nucleotide binding
por: Kim, Jeong Joo, et al.
Publicado: (2011)

Optogenetic manipulation of cyclic guanosine monophosphate to probe phosphodiesterase activities in megakaryocytes
por: Zhang, Yujing, et al.
Publicado: (2022)

PKC and AKT Modulate cGMP/PKG Signaling Pathway on Platelet Aggregation in Experimental Sepsis
por: Lopes-Pires, M. Elisa, et al.
Publicado: (2015)

The NO/cGMP/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders
por: Degjoni, Anisa, et al.
Publicado: (2022)

Co-Crystal Structures of PKG Iβ (92–227) with cGMP and cAMP Reveal the Molecular Details of Cyclic-Nucleotide Binding
por: Kim, Jeong Joo, et al.
Publicado: (2011)

Kinase activity profiling identifies putative downstream targets of cGMP/PKG signaling in inherited retinal neurodegeneration
por: Roy, Akanksha, et al.
Publicado: (2022)

Guanosine 3',5'-cyclic monophosphate and the in vitro physiology of frog photoreceptor membranes
Publicado: (1977)

Associations Between the Cyclic Guanosine Monophosphate Pathway and Cardiovascular Risk Factors: MESA
por: Ying, Wendy, et al.
Publicado: (2019)

Cyclic Guanosine Monophosphate–Adenosine Monophosphate Synthase (cGAS), a Multifaceted Platform of Intracellular DNA Sensing
por: Verrier, Eloi R., et al.
Publicado: (2021)

Src activation by cGMP/PKG II in osteoblasts: characterization of a mechano-sensitive signalling complex
por: Rangaswami, Hema, et al.
Publicado: (2011)

Protoporphyrin IX Stimulates Melanogenesis, Melanocyte Dendricity, and Melanosome Transport Through the cGMP/PKG Pathway
por: Lv, Jinpeng, et al.
Publicado: (2020)

Swimming exercise inhibits myocardial ER stress in the hearts of aged mice by enhancing cGMP-PKG signaling
por: Chang, Pan, et al.
Publicado: (2020)

Increased Adhesion and Aggregation of Platelets Lacking Cyclic Guanosine 3′,5′-Monophosphate Kinase I
por: Massberg, Steffen, et al.
Publicado: (1999)

Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin
por: Wetzl, Veronika, et al.
Publicado: (2016)

Mechanistic insights on novel small molecule allosteric activators of cGMP-dependent protein kinase PKG1α
por: Tawa, Paul, et al.
Publicado: (2022)

Treatment of Cardiovascular Dysfunction with PDE3-Inhibitors in Moderate and Severe Hypothermia—Effects on Cellular Elimination of Cyclic Adenosine Monophosphate and Cyclic Guanosine Monophosphate
por: Kuzmiszyn, Adrina Kalasho, et al.
Publicado: (2022)

Cryptosporidium parvum cyclic GMP-dependent protein kinase (PKG): An essential mediator of merozoite egress
por: Nava, Samantha, et al.
Publicado: (2020)

In Search of Enzymes with a Role in 3′, 5′-Cyclic Guanosine Monophosphate Metabolism in Plants
por: Gross, Inonge, et al.
Publicado: (2016)

Cardiac natriuretic peptides inhibit TRPC6-mediated prohypertrophic signaling through cGMP-PKG pathway
por: Kinoshita, Hideyuki, et al.
Publicado: (2009)

Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction?
por: Kovács, Á., et al.
Publicado: (2016)

Nitric Oxide Enhances Keratinocyte Cell Migration by Regulating Rho GTPase via cGMP-PKG Signalling
por: Zhan, Rixing, et al.
Publicado: (2015)

Burn-Induced Cardiac Mitochondrial Dysfunction via Interruption of the PDE5A-cGMP-PKG Pathway
por: Wen, Jake J., et al.
Publicado: (2020)

Heart Failure With Preserved Ejection Fraction and Obesity: Syndrome of cGMP-PKG Deficiency in Post-Menopausal Women
por: Sinha, Arjun, et al.
Publicado: (2020)

Role of G-Substrate in the NO/cGMP/PKG Signal Transduction Pathway for Photic Entrainment of the Hamster Circadian Clock
por: Plano, Santiago Andrés, et al.
Publicado: (2021)

Myocardial stretch-induced compliance is abrogated under ischemic conditions and restored by cGMP/PKG-related pathways
por: Leite-Moreira, André M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j66974b1vp6m6hsv3jbtan94mf